HIGHLIGHTS
- who: Iason Psilopatis and colleagues from the Department of Gynecology, Charitu00e9-Universitu00e4tsmedizin Berlin, Corporate Member of Freie Universitu00e4t Berlin and Humboldt-Universitu00e4t zu Berlin, Augustenburger Platz, Berlin, Germany Kapodistrian University of Athens, Athens, Greece have published the research: FDA-Approved Monoclonal Antibodies for Unresectable Hepatocellular Carcinoma: What Do We Know So Far?, in the Journal: (JOURNAL) of 21/Oct/2022
- what: The present review examines the current state of knowledge and provides a useful update on the safety and efficacy of these therapeutic agents thus attempting to define the suitability of each mAb for different . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.